Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check5 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.4%
- Check12 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference0.4%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe modernization of the ClinicalTrials.gov data ingest has been updated to July 2025, and the number of study locations has increased from 137 to 138.SummaryDifference0.5%
- Check34 days agoChange DetectedThe page has been updated to reflect a reduction in the number of study locations from 147 to 137, and the last update date has been changed to June 10, 2025.SummaryDifference1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check48 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.5%
Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.